Quasi-perfusion studies for intensified lentiviral vector production using a continuous stable producer cell line
Quasi-perfusion culture was employed to intensify lentiviral vector (LV) manufacturing using a continuous stable producer cell line in an 8-day process. Initial studies aimed to identify a scalable seeding density, with 3, 4, and 5 × 104 cells cm−2 providing similar specific productivities of infect...
Автори: | Dale J. Stibbs, Pedro Silva Couto, Yasuhiro Takeuchi, Qasim A. Rafiq, Nigel B. Jackson, Andrea C.M.E. Rayat |
---|---|
Формат: | Стаття |
Мова: | English |
Опубліковано: |
Elsevier
2024-06-01
|
Серія: | Molecular Therapy: Methods & Clinical Development |
Предмети: | |
Онлайн доступ: | http://www.sciencedirect.com/science/article/pii/S2329050124000809 |
Схожі ресурси
-
Continuous manufacturing of lentiviral vectors using a stable producer cell line in a fixed-bed bioreactor
за авторством: Dale J. Stibbs, та інші
Опубліковано: (2024-03-01) -
Process intensification for lentiviral vector manufacturing using tangential flow depth filtration
за авторством: Robert M. Tona, та інші
Опубліковано: (2023-06-01) -
Production of Lentiviral Vectors Using a HEK-293 Producer Cell Line and Advanced Perfusion Processing
за авторством: Michelle Yen Tran, та інші
Опубліковано: (2022-06-01) -
Establishment and Characterization of a Stable Producer Cell Line Generation Platform for the Manufacturing of Clinical-Grade Lentiviral Vectors
за авторством: Ane Arrasate, та інші
Опубліковано: (2024-10-01) -
Genome editing for scalable production of alloantigen‐free lentiviral vectors for in vivo gene therapy
за авторством: Michela Milani, та інші
Опубліковано: (2017-08-01)